Open AccessThe risk-oriented approach to the development and implementation of the pharmaceutical quality system in the production of in-bulk finished products
Author(s) -
О. П. Баула,
О. О. Салій,
Olena Shevchenko,
Tetiana O. Shevchenko
Publication year - 2021
Publication title -
upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï
Language(s) - English
Resource type - Journals
eISSN - 2519-8807
pISSN - 2311-1127
DOI - 10.24959/uekj.21.1
Subject(s) - quality (philosophy) , production (economics) , risk analysis (engineering) , pharmaceutical manufacturing , license , business , quality management system , control (management) , good manufacturing practice , order (exchange) , risk management , manufacturing engineering , quality management , operations management , computer science , management system , engineering , medicine , marketing , philosophy , supply chain , epistemology , artificial intelligence , economics , pharmacology , macroeconomics , operating system , finance
Aim. To determine the areas of the risk-based approach to the development and implementation of the pharmaceutical quality system with the emphasis on the production of in-bulk finished products, identify the main factors affecting the stability of the functional characteristics of drugs in order to provide their compliance with the international quality standards, Good Manufacturing Practice and quality risk management.Results. 29 pharmaceutical companies with the license in Ukraine for dispensing and packing of medicines from in-bulk products have been identified. The control strategy for the production of medicines for in-bulk products has been developed as a set of measures covering the incoming control of in-bulk products, the primary, secondary packing and their labeling, patient information leaflets, finished drug at release and shelf life, control of operating conditions of premises and equipment, parameters of dispensing and packing stages. The analysis of the specificity of the production of finished drugs from in-bulk products has been performed, and the areas of the risk-oriented approach have been determined to the development and implementation of the pharmaceutical quality system in this type of production based on the risk assessment of significant factors affecting the pharmaceutical production and the use of the appropriate risk management methods for quality in the production of medicines from in-bulk products.Conclusions. It has been determined that the risk-oriented approach to the development and implementation of the pharmaceutical quality system in the production of medicines from in-bulk products is a strategic direction. It allows increasing the effectiveness of the quality management system at a qualitatively new level, achieving goals in order to prevent adverse effects on quality and safety, and it means the best possible customer satisfaction. In our research, the quality guarantees that the pharmaceutical quality system should provide in the production of medicines from in-bulk products have been identified, and the control strategy has been developed.Key words: in-bulk products; medicines; drug quality; risk-based approach; pharmaceutical quality system; Good Manufacturing Practice; quality risk assessment